Journals / Turkish Journal of Hematology / 2002 / Cilt: 19 - Sayı: 2

Biological determinants of fasting and postload plasma homocysteine levels in healthy Italian subjects

Pages
213–223
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results demonstrate that age and vitamin status differently influence both the fasting and the postmethionine plasma homocysteine levels in normal subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Genetic and nutritional factors are determinants of total plasma homocysteine (tHCy) whose increased levels play a pathogenic role in atherothrombosis and cardiovascular disease.
📊
Key Findings & Data:This study investigated the influence of sex, age, creatinine, serum folate, vitamin B12 and vitamin B6 (pyridoxal-5-phosphate, PLP) on fasting (FtHCy) and two hour postmethionine loading levels of tHCy in 147 apparently healthy subjects (M/F= 82/65, age range: 14-94 y).
💡
Conclusion & Impact:These results demonstrate that age and vitamin status differently influence both the fasting and the postmethionine plasma homocysteine levels in normal subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Cinsiyet faktörleri · Homosistein · Yaş dağılımı

Özet

Genetic and nutritional factors are determinants of total plasma homocysteine (tHCy) whose increased levels play a pathogenic role in atherothrombosis and cardiovascular disease. This study investigated the influence of sex, age, creatinine, serum folate, vitamin B12 and vitamin B6 (pyridoxal-5-phosphate, PLP) on fasting (FtHCy) and two hour postmethionine loading levels of tHCy in 147 apparently healthy subjects (M/F= 82/65, age range: 14-94 y). FtHCy was higher in men than women (9.89 vs 8.00 µmol/L, p< 0.01). In males, the main determinants of FtHCy were age and folate levels, respectively explaining 20.5% and 19.0% of FtHCy variance. In women, besides age (22.6%), vitamin B12 (17.8%) rather than folate was a major determinant of FtHCy. Two hour postload tHCy, expressed both as absolute value (PML) and as the difference between 2 hour postload tHCy and FtHCy (delta tHCy) was negatively correlated with folate in both sexes, and with vitamin B12 and age in women only. In males folate was the main determinant, explaining 20% of the variance of postload values, while in females vitamin B12 and PLP were predominant, explaining respectively 40% and 20% of that variance. Age was not among the main determinants of postload values in either sex. These results demonstrate that age and vitamin status differently influence both the fasting and the postmethionine plasma homocysteine levels in normal subjects.

🔖

Cite This Article

SASSI, S., COSMI, B., PALARETİ, G., LEGNANI, C., SALARDI, S., COCCHERI, S. (2002). Biological determinants of fasting and postload plasma homocysteine levels in healthy Italian subjects. Turkish Journal of Hematology, Cilt: 19 - Sayı: 2, 213–223. https://ajindex.com/articles/412986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, Denheijer M, Kluijt- mans LA, Van Den Heuvel LP, Rozen R. A candida¬ te genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Am J Hum Genet 1991;48:536-45
  2. Mudd SH, Levy HL, Skovb YF. Disorders in trans- sulfuration. In: Scriver CR, Beaudef AL, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Metabolic Diseases. New York, NY: Me Graw Hill, 1995:1279-327
  3. Ubbink JB, Vermaak WJH, Van Der Merwe A.M, Becker PJ. Vitamin B12, vitamin B6 and folate nut¬ ritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53
  4. Pietrzik K, Bronstrup A. Causes and consequences of hyperhomocysteinemia. Internat J Vit Nutr Res 1997;67:389-95
  5. Palareti G, Salardi S, Piazzi S, Legnani C, Poggi M, Grauso F, Caniato A, Coccheri S, Cacciari E. Blood coagulation changes in homocystinuria: The effects of pyridoxine and other specific therapy. J of Pedi¬ atrics 1986; 109:1001-6
  6. Refsum H, Ueland PM, Nygard O, Vollset SE. Ho¬ mocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62
  7. Legnani C, Palareti G, Grauso F, Sassi S, Grossi G, Piazzi S, Bernardi F, Marchetti G, Ferraresi P, Coc¬ cheri S. Hyperhomocyst(e)inemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val, MTHFR) in patients with inherited thrombophilic coagulation defects. Atherosclerosis, Thrombosis and Vascular Biology 1997; 17:2924-9
  8. Palareti G, Legnani C, Coccheri S. Hyperhomocis- teinemia and vascular disease. Hypercoagulable sta¬ tes. Fundamental Aspects, Acquired Disorders, and Congenital Thrombophilia. Boca Raton: CRC Press, 1996:395-407
  9. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, d Davignon J. Plasma total homocysteine in.healthy subjects: Sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93
  10. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine be¬ fore and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87
  11. Russel RM. Changes in gastrointestinal function att¬ ributed to aging. Am J Clin Nutr 1992;55:12203-7
  12. Wilcken DEL, Wilcken B. The pathogenesis of coro¬ nary artery disease, a possible role for methionine metabolism. J Clin Invest 1976;57:1079-82
  13. Sardharwalla IB, Fowler B, Robin AJ, Komrower GM. Detection of heterozygotes for homocystinuria. Arch Dis Child 1974;49:5